Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira for Intestinal Inflammation in Ankylosing Spondylitis
NCT01174186Phase 4Completed
- Sponsor
- Regionshospitalet Silkeborg
- Start
- Oct 2010
- Primary completion
- Jun 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, open-label trial of adalimumab in axial spondyloarthritis (axSpA) and enterocolitis, sponsored by Regionshospitalet Silkeborg. Primary endpoint: Lewis Score Index at 20 weeks. Started Oct 2010; status: completed.
02
Drugs
03
Conditions
axial spondyloarthritis (axSpA)enterocolitis
Beyond the preview
Go deeper on NCT01174186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174186.